{"name":"Forward-Pharma GmbH","slug":"forward-pharma-gmbh","ticker":"","exchange":"","domain":"","description":"Forward-Pharma GmbH is a biotechnology company focused on the development of innovative treatments. The company's primary focus has been on FP187, which was discontinued in its development phase.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"The Manila Times","summary":"Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with 'gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access ","headline":"Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with 'gesund leben” Cooperation and Alliance Healt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNMTN5ZFBJSU5aa1dFMzctLWZoMVFLRWszSVlBRlpBV0pkZTRNbWl4WlczSUJ6WlAybHk2OGFUcmx4TUdLNTNvZ0hVR2hKVVZLWlhzNmR2NFVyYlFyV1FPS2lGSXM4VFZEYUFPTHo5QUp5MVpSaTJGT1FHZ2owX1MzYWVrQkVhMmdtNWtyd1lVVTljems3VG5rbUlkUTRlRkNsSlhTUlFqSkExSWJVUmY4NHJWT0dVVEhwcHlCeW1DY1A3aHozLWhYcTJMUFFDV2Q1Z0o0ZElkVjlWdVJWNklNZll5RGc?oc=5","date":"2026-02-12","type":"pipeline","source":"Quiver Quantitative","summary":"Tilray Pharma and Smartway Pharmaceuticals Forge Strategic Agreement to Enhance Pharmaceutical Distribution in the UK - Quiver Quantitative","headline":"Tilray Pharma and Smartway Pharmaceuticals Forge Strategic Agreement to Enhance Pharmaceutical Distribution in the UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQcWhnMEJpU21yLXkwdk8zQXI0YnJHTXZJTGpfQmJ0V3JtQVBpYjk0cnJOUUJaS1VvZE1jRGsxN0ZMN213QzRkTElvMDI1VjdDVFRQdmRZenpUUHo1LXpsNTF3Nkw5ME5IQ0Jzc3BJS1ZrMWFJSFVleU42dlFWTjRvV0JYS0lrMlZNSFRGcFZIaHhvT0p3cjQ3a0FKa0RYa2IzejZ6YXRKbjN3RmtCSzNfemc1YmsxZnZNOU1rLUZxZw?oc=5","date":"2026-02-12","type":"pipeline","source":"Stock Titan","summary":"Tilray–Smartway pact aims to steady UK medicine supplies - Stock Titan","headline":"Tilray–Smartway pact aims to steady UK medicine supplies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQU3hQNWlSV3NHTUNnN1R1Um1POV91M2FNS1hyaXJIUzNIRTdLVzVZMDRVTDhjVWp0Uy1fX3RnUF9ma0VpcFhYX242ejBKaXBmR0VKcjgwdUdyTWJwSE85UUxwQjAzVHh4RjU4c29UQTZBWTdleUFmcWl5YlhTazhNOTMyNGFFXzYtNC1YeEU2NmhnVklTVUoxcnRFcjI3WDhpZF9RX0RCTnp1aUlhSVQ5RHgzelNWZ0NNQlZobFdoZU8yNWkyOXZjN1AyUGpJVzdHWEdiQTR6ZUJ3NWZXaklQNlRUMFBvQm5CR2lrLUNLTVNiYTVZYXVCb1VSYlo4ajVpYkp4d0xZeW9zQkZfUXpyMlFn?oc=5","date":"2025-12-03","type":"patent","source":"BioSpace","summary":"Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System - BioSpace","headline":"Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprieta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxOMnRZV0F2dWxZZ05sclZzaHZheHg4MjhjY0hKM2toSzhLek9SV0hpR0ZVNGNhTHI4bkw1NFktTnJLWll6S2lpQXdHLXhQb0ZsQ0hpVzdaYkhIOThZMkVLMDQ1VnRoajY5dXdsZGhObHl3NjBVdTUyNHVjdjFOVXVMbHUxeW16QjRmeTJsb0J3TnRIb21aZ0ZKdmd5YmpIMzR5QmNkVlFucEhKYW5RTnJlNmsycXpoOXA4UHBtY0g1TjRNYnF4enJlazFQenNHN3B4c3hTOGpVQkh4SjQtbkhndG0wWXNVeXljR0xzd3hTYXBoUUhwOVhmbkY2c2gyYVBUNmN5c0JjUmFlbDFPZ211NFY3bmszcUtMa3dqdE0wQzZGb2JRTVY1N2JCYTJGX1RMdnZad290WTFHdC1oaVBlX3dGV0k5YUlJNVhibWJtYWJ1UQ?oc=5","date":"2025-11-04","type":"pipeline","source":"Business Wire","summary":"Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody - Business Wire","headline":"Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQX1l6UzZuUVk4UnVwWHVLRVJaTHh6eFRnZGhMd2s0ZlRNWHV6QmxfMXo1aGUyNUtqNHV6bGFQelFvdHltUUVEaGtPUDBzVjIwQ1RxZVNvYUpZMjJfV3F0OUZmMXpBSzNuUG1Ta0VmX3JjYlBLM0pGRmRfM3hyN0puZVVSNV82NmlKTW5ZR0QtQXQ4NW9zdHVsWDM3MkpJcVVkcUlBaXp1QUxidGpwWDlKU3pnZXVHaGhFbTEtWms4bUNFNWpZRUxIR0VzUldJMmx1eHFaT2ZSbnhxSlhEN2ZCUmRfSEwtWUprOENMNjZTZ2VGTmpWRmJXWVRUUUM?oc=5","date":"2025-09-02","type":"pipeline","source":"GlobeNewswire","summary":"Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million - GlobeNewswire","headline":"Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPazZzbG5STmlFYzh2eWtIODhPNjNLb1UzNC0taGdlN2ZSYjJ4a3hMNVJMSi1kNDI5VXRveHZlS21xVGRCRXN1OEJITWJGX29ER1BRMVZxNGl6ODJCT3pqQ2w3TjNFcTZOTG43RkFFZHBMMF9rT2FNdWs5UzZkNmtNWGxmMWVDd19GeUM3emdCVklmd2c3SjZ3T0FlUTRiX1lwdGFUb05rR3Y1LWpjdXRTa3pnLURFM25hWU10Z0FQZEFHcjk2N01zQzU3ZmlOeG5LQk9zN0lYNW85SU1QaGdKTUx3WGFJWkdQQm13SXY0VTl5OE9WYVZ3VmVOWjI2ejlKaWdYN3FtQQ?oc=5","date":"2025-09-02","type":"pipeline","source":"Cannabis Business Times","summary":"High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH - Cannabis Business Times","headline":"High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOS0dsOEk3MFRqSVR6NVlydzFJcmhYREttZWNqWFN1dmVNRS15eWtyblYzNmlDYnp5LWpaX1AzOEFMRERYQUxYV0FtMi1YSHgtVzdxTTI4Z3QtdE9FSWFzQW4xT2lZcC1YdkR5d2Q0cExhWk5QWkRMbFhuSWhWaGdpbmlTUDBseW4xOUpCd0hPTmRTbGtFUnhodjJfcDVzUU5sdm5teWJTR0MzMUZOX2FWLWZlUXoydHZnNU5NYkVuSlVLSGJsZ1JrYkhCaG5FY3BjbS1kdGtTY19wSG0zblpIekF1QQ?oc=5","date":"2025-05-23","type":"pipeline","source":"BioSpace","summary":"Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis - BioSpace","headline":"Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRFE1MURTRUhqZTFqa0Jzb3lDaEQ1VDNMaFZmaFJQTlJPeE9ISVVBQTNCMG5HU0NBeTJyRzl4ZzJqVGp6d21YTG40cVNvMENOT0IyWjRPdTg4VThkSHdPYk9hVGpaWWhUWmxYX3lkVjY4bEFVeHBtXzdLU3dtZm1pRUxOcDFla240WVJjcEFQemVTZ1lleDJGZUhzLTV4RjZiNjc1WnN3?oc=5","date":"2025-02-08","type":"pipeline","source":"bain.com","summary":"Healing the World: A Roadmap for Making India a Global Pharma Exports Hub - bain.com","headline":"Healing the World: A Roadmap for Making India a Global Pharma Exports Hub","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPX3hHeTVGR0g5RGlTVFp3eG5JYTZwbU5kOGhEMkhSczd4WGpnNF9NR21Fc1NvRmp0ek41b3gtWVlTVnZuWHhveHo3Zlk5ODJGb3lrdGY2TWVHX09FTy1RTFN6MEE5XzZPS0gwTGl5MWJteTNtdmMyMGJmeVBkR1Bqd2NfWDNubjlOaFF3OHJ2RnhWVUdIb3lIY0pjem5CY1NWdzJOZEEtSW1MRFRCNW9hWTRfejZVamVBVHhyT0d2RjFqUmN0aWRKS3BNZnFyY0JMRHphRjBzdnJ4bkY3N2oxNU5rWVFkenR5dzRIUkZDbFEtVkJiT2c?oc=5","date":"2024-11-26","type":"pipeline","source":"PR Newswire","summary":"Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer - PR Newswire","headline":"Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxNaU9tSzQ2SE5ucTVEb1lkd0V4UkVFTE9RbXU3b1hwWk1SS1F2c1JCMHNvTlJkQjRERXhRaEYzNTBZQVNrMXpPYTVsbzJIa3VqZUY4S0huX091NWdOeVpuWFM4ZWpQNHowbEpDU3EtWGQ5amZMdHZHQVBJMkFSZE8zd01EU1IwWnlTSnhibDhzTENJZG0yUkFNTlZoVnRQakoyUXMyZ3lTckQ4cWRyR3pCdGJLQXloLTJNNzFVSE5RVjlwZnliYnkyYkxZZVhLTlpqRXFsRy1FeV95WUJrV09IZ0ZNNko5Y2FTdDdjOVdrR0hpSnc?oc=5","date":"2021-06-02","type":"regulatory","source":"Boehringer Ingelheim","summary":"Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH - Boehringer Ingelheim","headline":"Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWXl5UlNXVFNmWEhGcWhQZ2lBaFZmcWVhRXVNRVF0VlZJVVBnYUswTXE0YmotdEd6cVpwYjd2VlNTVS1XalZ6b2dXRG9VWXV2S294aGdoa0taVW9zVmxCMHg1NXM1Nnh6aEtMTWExazJNUG9DM21abnRYT3NyUnNmTVotX2NnWU96bUQ1M0hqSVE4R2UwZThiMGpRdEdOakpTZ1BTRHA2MFQzTEhOelZiSUp6U1BfVE1CYWduVzNpc0JrZw?oc=5","date":"2017-01-17","type":"deal","source":"Biogen","summary":"Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement - Biogen","headline":"Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}